hu14.18 (K322A) is a humanized monoclonal antibody targeting disialoganglioside GD2, comprised of a fully human amino acid sequence of immunoglobulin G1 heavy chain and kappa light chain. This antibody exhibits antibody-dependent cellular cytotoxicity (ADCC) and is utilized in studying high-risk neuroblastoma.
Target-Kategorie:
Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten